author-photo

Patrick J. Stiff

Loyola University Chicago
Loyola University Medical Center

340

Papers

14545

Citations

Citation Trend

Filter By

Papers (340) Sort By

Journal Conference Others

Motixafortide (BL-8040) and G-CSF Versus Placebo and G-CSF to Mobilize Hematopoietic Stem Cells for Autologous Stem Cell Transplantation in Patients with Multiple Myeloma: The Genesis Trial

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Clinical Experience in the Randomized Phase 3 Sierra Trial: Anti-CD45 Iodine ( 131 I) Apamistamab [Iomab-B] Conditioning Enables Hematopoietic Cell Transplantation with Successful Engraftment and Acceptable Safety in Patients with Active, Relapsed/Refractory AML Not Responding to Targeted Therapies

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Long-Term (≥4 Year and ≥5 Year) Overall Survival (OS) By 12- and 24-Month Event-Free Survival (EFS): An Updated Analysis of ZUMA-1, the Pivotal Study of Axicabtagene Ciloleucel (Axi-Cel) in Patients (Pts) with Refractory Large B-Cell Lymphoma (LBCL)

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Prophylactic Corticosteroid Use with Axicabtagene Ciloleucel (Axi-Cel) in Patients (Pts) with Relapsed/Refractory Large B-Cell Lymphoma (R/R LBCL): One-Year Follow-up of ZUMA-1 Cohort 6 (C6)

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Effect of time to relapse on overall survival in patients with mantle cell lymphoma following autologous haematopoietic cell transplantation

2021 British Journal of Haematology
Show All
- Source
- Cite
- Save
Citations (0)
857TiP An open-label, multicenter, phase II study of CLR 131 in patients with relapsed or refractory (R/R) select B-cell malignancies (CLOVER-1) and expansion cohort in patients with waldenstrom macroglobulinemia (CLOVER-WaM)

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
The Use of a Fitbit Physical Activity Monitor Device Among Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT)

2021
Show All
- Source
- Cite
- Save
Citations (0)
CLR 131 (Iopofosine I-131) Treatment in Triple Class Refractory and Beyond Multiple Myeloma Patients: Preliminary Efficacy and Safety Results from the Phase 2 Clover-1 Trial

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Multicenter, Open-Label, Phase 3 Study of Tabelecleucel for Solid Organ or Allogeneic Hematopoietic Cell Transplant Recipients with Epstein–Barr Virus-Driven Post Transplant Lymphoproliferative Disease after Failure of Rituximab or Rituximab and Chemotherapy (ALLELE)

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Umbilical Cord Blood as an Alternate Donor Sources for High Risk Elderly Patients Undergoing Allogeneic Stem Cell Transplantation for Hematological Malignancies

2021
Show All
- Source
- Cite
- Save
Citations (0)